Fact CheckerSign in

NCT04835493Active, not recruiting

Evaluating Telementoring for CHW-centered Diabetes Initiatives

Evaluating Telementoring to Initiate a Multidimensional Diabetes Program for Latino(a)s in Community Clinics: A Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 14 Oct 2026

Brief summary (registry, in English)

Diabetes care is complex and requires a multidimensional approach, but interventional programs are difficult to initiate in low-income and minority populations. In the proposed study, investigators will mentor local clinics via telehealth to initiate our diabetes program involving telehealth-support, integrated CHWs, medication-access, and diabetes Education into their clinics. Mentoring local clinics to initiate this intervention is a promising strategy to enhance sustainable diabetes care and reduce disparities in vulnerable minority populations.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
320 (actual)
First submitted
5 Apr 2021
Start date
1 Sept 2022
Primary completion date
30 Apr 2025
Lead sponsor
The University of Texas Medical Branch, Galveston
NCT number
NCT04835493

What you commit to

  • Study type: Interventional
  • Participants enrolled: 320
  • From 1 Sept 2022 to the primary completion date, 30 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • condition that may alter HbA1c levels, e.g., recent blood transfusion
  • patients at high-risk or not appropriate for care in a group setting e.g., pregnancy, severe cognitive impairment, frequent clinic appointments for labile glucose/medication titration e.g., insulin.

Other

  • no show to all group visits

Who the study is looking for

  • self-identified Latino(a)
  • Spanish-speaking
  • \>/=18 years
  • type 2 diabetes (T2D), e.g., HbA1c \>/=6.5%, provider documented T2D, on oral anti-hyperglycemic
  • uninsured, \<150% federal poverty level

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas Medical Branch
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.